Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Hawkes
Safety Analysis of Australasian Leukaemia & Lymphoma Group Nhl29: A Phase Ii Study of Ibrutinib, Rituximab and Mini-Chop in Very Elderly Patients With Newly Diagnosed DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Rituximab, Lenalidomide, and Ibrutinib Alone and Combined With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Accept: A Phase Ib/Ii Combination of Acalabrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop) for Patients With Diffuse Large B-Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Lenalidomide and Obinutuzumab With Chop for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I/Ii Results
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Da-Epoch-R Versus R-Chop in High Risk DLBCL Patients: Analysis of the Czech Lymphoma Study Group (Clsg)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone Prior to Combination With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combination of Ibrutinib With Rituximab (Ir) Is Highly Effective in Previously Untreated Elderly (>65 Years) Patients (Pts) With Mantle Cell Lymphoma (Mcl) - Phase Ii Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bendamustine and Rituximab in Elderly Patients With Low-Tumour Burden Follicular Lymphoma. Results of the LYSA Phase II BRIEF Study
British Journal of Haematology
Hematology
Bortezomib Maintenance After R-Chop, Cytarabine and Autologous Stem Cell Transplantation in Newly Diagnosed Patients With Mantle Cell Lymphoma, Results of a Randomised Phase II HOVON Trial
British Journal of Haematology
Hematology
